Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hematopoietic Cell Kinase (Hck)
- Target
- Hck
- Molecular classification
- Enzyme, Protein Kinase, Tyrosine Kinase, Non-receptor tyrosine kinase, Src family kinase (SFK)
01
Overview
Hck (hematopoietic cell kinase) is a non-receptor tyrosine-protein kinase belonging to the Src family of kinases (SFKs). It is primarily expressed in myeloid and B-lymphocyte lineage cells, where it plays a crucial role in immune cell signaling, inflammation, and cellular processes like phagocytosis and migration. Hck regulates actin-dependent processes, participates in NLRP3 inflammasome formation, and modulates LPS-induced inflammatory responses. Dysregulation of Hck is implicated in various inflammatory diseases, making it a potential therapeutic target.
- Other names
- Tyrosine-protein kinase HCKp59HCKp61HCK
02
Mechanism of action
Hck inhibitors block the kinase activity of Hck, preventing phosphorylation of downstream targets involved in inflammatory signaling and cellular processes.
03
Biological functions
Signal transductionImmune response regulationInflammation regulationPhagocytosisActin remodelingCell migrationCytokine productionNLRP3 inflammasome assembly
04
Disease associations
InflammationAutoimmune diseasesSepsisPneumoniaVasculitisImmune dysregulation
05
Safety considerations
Potential for off-target effects due to similarity with other SFKs.Functional redundancy with other SFKs may limit efficacy.Long-term effects of Hck inhibition on immune function are not fully understood.
Beyond the preview
Go deeper on Hematopoietic Cell Kinase (Hck).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hematopoietic Cell Kinase (Hck).